ID: ALA3273608

Max Phase: Preclinical

Molecular Formula: C44H67N11O12S2

Molecular Weight: 1006.22

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O

Standard InChI:  InChI=1S/C44H67N11O12S2/c1-5-24(4)37-43(66)50-27(12-13-33(45)57)39(62)52-31(21-34(46)58)40(63)51-28(14-17-68-69-18-15-36(60)49-30(41(64)54-37)20-25-8-10-26(56)11-9-25)44(67)55-16-6-7-32(55)42(65)53-29(19-23(2)3)38(61)48-22-35(47)59/h8-11,23-24,27-32,37,56H,5-7,12-22H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,60)(H,50,66)(H,51,63)(H,52,62)(H,53,65)(H,54,64)/t24-,27-,28-,29-,30-,31-,32-,37-/m0/s1

Standard InChI Key:  GNZQVXDEKUKUFY-VNHOCEMUSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 1006.22

Molecular Weight (Monoisotopic): 1005.4412

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Smith CW, Ferger MF..  (1976)  Synthesis and some pharmacological properties of five analogs of oxytocin having L-homocysteine in position 6.,  19  (2): [PMID:1249804] [10.1021/jm00224a010]

Source

Source(1):

• Scientific Literature